YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-10
DOI
10.1186/s13045-021-01124-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
- (2021) Ying Qing et al. MOLECULAR CELL
- EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
- (2021) Runping Fang et al. Nature Communications
- Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
- (2021) Zheng Zhao et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma
- (2021) Yu-Zhou Chang et al. CANCER LETTERS
- Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer
- (2020) Qiang Wang et al. Journal of Hematology & Oncology
- Role of CX3CR1 Signaling in Malignant Transformation of Gliomas
- (2020) Sungho Lee et al. NEURO-ONCOLOGY
- YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
- (2020) Chuanzhao Zhang et al. ONCOGENE
- The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
- (2020) Rui-Chao Chai et al. Acta Neuropathologica Communications
- RNA modifications in brain tumorigenesis
- (2020) Albert Z. Huang et al. Acta Neuropathologica Communications
- MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
- (2020) Barbara Oldrini et al. Nature Communications
- The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells
- (2020) Deobrat Dixit et al. Cancer Discovery
- Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
- (2020) Yu-Zhou Chang et al. Frontiers in Cell and Developmental Biology
- Clinical practice guidelines for the management of adult diffuse gliomas
- (2020) Tao Jiang et al. CANCER LETTERS
- Endoribonucleolytic Cleavage of m6A-Containing RNAs by RNase P/MRP Complex
- (2019) Ok Hyun Park et al. MOLECULAR CELL
- m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
- (2019) Rui-Chao Chai et al. Aging-US
- Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma
- (2019) Rui-Chao Chai et al. CARCINOGENESIS
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- N6-methyladenosine Modulates Nonsense-mediated mRNA Decay in Human Glioblastoma
- (2019) Fuxi Li et al. CANCER RESEARCH
- The interplay between m6A RNA methylation and noncoding RNA in cancer
- (2019) Shuai Ma et al. Journal of Hematology & Oncology
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
- (2018) Ying Yang et al. CELL RESEARCH
- Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
- (2018) Romain Appay et al. Acta Neuropathologica Communications
- NF-κB, Mesenchymal Differentiation and Glioblastoma
- (2018) Bakhtiar Yamini Cells
- Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
- (2018) Huimin Hu et al. CELL
- YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
- (2018) Li Zhong et al. CANCER LETTERS
- PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
- (2018) Zuoxin Zhang et al. CANCER LETTERS
- Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
- (2017) A Visvanathan et al. ONCOGENE
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
- (2016) Genaro R. Villa et al. CANCER CELL
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex
- (2016) Hao Du et al. Nature Communications
- Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
- (2015) Fabiola Bovenga et al. Cell Metabolism
- Ubiquitin-associated Domain-containing Ubiquitin Regulatory X (UBX) Protein UBXN1 Is a Negative Regulator of Nuclear Factor κB (NF-κB) Signaling
- (2015) Yu-Bo Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries
- (2013) Rui Chao Chai et al. GLIA
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- Genome-wide Repression of NF-κB Target Genes by Transcription Factor MIBP1 and Its Modulation by O -Linked β- N -Acetylglucosamine ( O -GlcNAc) Transferase
- (2012) Yuji Iwashita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started